bioRxivMicrobiology
Degradation of the incretin hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis metalloprotease GelE
Abstract
Metabolic diseases, including Type 2 Diabetes and obesity, have become increasingly prevalent global health concerns. Studies over the past decade have established connections between the gastrointestinal microbiota and host metabolism, but the mechanisms behind these connections are only beginning to be understood. We were interested in identifying microbes that have the ability to modulate the levels of the incretin hormone glucagon like peptide 1 (GLP-1). Using a human derived cell line that is capable of secreting GLP-1 in response to stimulatory ligands (NCI-H716), we identified supernatants from several bacterial isolates that were capable of decreasing GLP-1 levels, including several strains of Enterococcus faecalis. We further identified the secreted protease GelE, an established virulence factor from E. faecalis, as being responsible for GLP-1 inhibition via direct cleavage of GLP-1 by GelE. Finally, we demonstrated that E. faecalis supernatants can disrupt a colonic epithelial monolayer and cleave GLP-1 in a gelE dependent manner. This work suggests that a secreted factor from an intestinal microbe can traverse the epithelial barrier and impact levels of an important intestinal hormone.\n\nImportanceHumans have a complex and interconnected relationship with their gastrointestinal microbiomes, yet our interest in the microbiome tends to focus on overt pathogenic or probiotic activities, leaving the roles that commensal species may have on host physiology and metabolic processes largely unexplored. Commensal organisms in the microbiome produce and secrete many factors that have an opportunity to interact with the gastrointestinal tract and host biology. Here we show that a secreted protease from E. faecalis, GelE, is able to degrade the gastrointestinal hormone GLP-1, which is responsible for regulating glucose homeostasis and appetite in the body. The disruption of natural GLP-1 signaling by GelE may have significant consequences for maintaining healthy blood glucose levels and in the development of metabolic disease. Furthermore, this work deepens our understanding of specific host-microbiome interactions.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease
C. Tomaro-Duchesneau, S. L. LeValley, … R. A. Britton·bioRxiv·Jul 29, 2018
- Determination of GLP-1 Secretion Potential of Dead and Live Akkermansia muciniphila Using Human L-cells
Subhendu Nayak, Prabhu Rajagopalan, … Shalini Jain·bioRxiv·Mar 20, 2026
- Gut microbiota DPP4-like enzymes are increased in type-2 diabetes and contribute to incretin inactivation
M. Olivares, P. Hernandez-Calderon, … A. Benitez-Paez·bioRxiv·Dec 18, 2023
- The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis by enhancing GLP-1 secretion and L-cell differentiation
Phyllis Phuah, Mariana Norton, … Kevin G. Murphy·bioRxiv·Jun 24, 2025
- G protein-coupled receptor 17 inhibits glucagon-like peptide-1 secretion via a Gi/o-dependent mechanism in enteroendocrine cells
Jason Michael Conley, Alexander Jochim, … Hongxia Ren·BiomoleculesPeer-reviewed·Dec 25, 2024
- Endosomal free fatty acid receptor 2 signaling is essential for propionate-induced anorectic gut hormone release
N. Caengprasath, N. Gonzalez-Abuin, … A. Hanyaloglu·bioRxiv·Mar 24, 2020